This compound is primarily used in organic synthesis as a chiral building block or intermediate in the production of pharmaceuticals and fine chemicals. Its structure, featuring a pyrrolidine ring and a trifluoroacetyl group, makes it valuable for introducing chirality and fluorine atoms into target molecules. It is often employed in the synthesis of bioactive compounds, particularly in the development of drugs targeting neurological disorders, cardiovascular diseases, and other therapeutic areas. The tert-butyloxycarbonyl (Boc) protecting group enhances its stability during synthetic processes, allowing for selective reactions and easier purification. Additionally, its trifluoroacetyl moiety can serve as a precursor for further functionalization, making it a versatile reagent in medicinal chemistry and drug discovery.